
    
      The objective of this study is to evaluate the reliability of the Ablacon Electrographic Flow
      (EGF) algorithm technology (Ablamap Software) to identify atrial fibrillation sources and
      guide ablation therapy in patients with persistent atrial fibrillation.
    
  